Note: Ingredients listed on restricted chemical lists
EC/CAS
532-32-1
Name of the chemical
Benzoic acid and its sodium salt
Concentration
N/A
EC/CAS
69-65-8
Name of the chemical
D-mannitol C6H14O6
Concentration
N/A
EC/CAS
5989-27-5
Name of the chemical
(R)-p-mentha-1,8-diene
Concentration
N/A
EC/CAS
104-55-2
Name of the chemical
Cinnamaldehyde/3-phenyl-propen-2-al
Concentration
N/A
General Information
Revision date
2021-11-29
Product name
Valganciclovir Hydrochloride for Oral Solution, 50 mg/mL
Icons in SDS
Company Information
company name
GRANULES PHARMACEUTICALS, INC
GHS Information
Signal word
Toxic
Section 2
SECTION 2: Hazards identification
Signal word
Toxic Danger
Hazard statements
The Active Ingredient Valganciclovir Hydrochloride has been identified having a possible risk of genetic defects, suspected of causing cancer and may damage fertility or the unborn child
2.3 Other hazards
The Product can support combustion. The ignition of dust in certain conditions can cause and explosion. Dust may be sensitive to electrostatic ignition sources. In case of fire, may emit toxic fumes (oxides of nitrogen, carbon)
PBT Substances
Not Classified
Precautionary statements
Obtain special instructions before use, do not handle until all safety precautions have been read and understood, use personal protective equipment as required, if exposed or concerned: get medical advice/attention
